Leadership

Joel Bradley, a PhD organic chemist from MIT, founded Cambridge Isotope Laboratories (CIL) in 1981. From the beginning, CIL's mission has been to drive the expansion of market applications of stable isotopes with innovative product development while providing the highest quality product and unsurpassed service to our customers.

Joel Bradley, a PhD organic chemist from MIT, founded Cambridge Isotope Laboratories (CIL) in 1981. From the beginning, CIL's mission has been to drive the expansion of market applications of stable isotopes with innovative product development while providing the highest quality product and unsurpassed service to our customers. Since 1981, CIL has worked with leading scientific groups in the fields of environmental ultratrace analysis, metabolic research, molecular biology, protein structure analysis, clinical and diagnostic research, who have turned to the use of stable isotopes in order to solve their most demanding problems.

Dr. Bradley and the CIL Executive Team all share the same commitment to quality and service.

Peter Dodwell serves as the President and Chief Operating Officer of Cambridge Isotope Laboratories, Inc.

Peter Dodwell serves as the President and Chief Operating Officer of Cambridge Isotope Laboratories, Inc.

Maureen Duffy joined CIL in 1983 and is currently the Vice President of Sales and Marketing.

Maureen Duffy joined CIL in 1983 and is currently the Vice President of Sales and Marketing. Maureen received a BA in Journalism from the University of Massachusetts.

Steven Igo is Vice President of Finance, and joined Cambridge Isotope Laboratories, Inc. in 1994. He received his undergraduate degree from Bentley College and a MBA in Finance from Suffolk University.

Steven Igo is Vice President of Finance, and joined Cambridge Isotope Laboratories, Inc. in 1994. He received his undergraduate degree from Bentley College and a MBA in Finance from Suffolk University.